Novartis makes a $1B radiopharma deal, buying Mariana Oncology
Novartis will pay $1 billion upfront to acquire radiopharmaceutical startup Mariana Oncology, just eight months after the preclinical biotech company disclosed a $175 million Series B. The move, which could include another $750 million in milestones, further solidifies the Swiss drug giant’s embrace of the red-hot field of radiopharmaceuticals. Novartis